T

    TERN (TERN)

    Official site

    BIOTECHNOLOGY

    $52.95
    +0.00 (+0.00%)

    Last updated: May 05, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    82%(18/22)
    Avg Surprise
    -140.44%
    Streak
    10 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$-0.28
    Range$-0.34 - $-0.24
    3 analysts
    EPS Revisions
    1
    0
    7d
    3
    1
    30d
    EPS Estimate Drift
    90d ago$-0.32-14.5%
    60d ago$-0.30-9.3%
    30d ago$-0.29-3.5%
    7d ago$-0.28-3.0%
    Current$-0.28
    Revenue Consensus
    $0
    Range$0 - $0
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26EST
    		-$-0.28---
    Mar 26
    Reported Mar 31
    		$-0.24$-0.26+9.04%Beat+7.9%
    Dec 25
    Reported Mar 31
    		$-0.24$-0.30+19.97%Beat+0.0%
    Sep 25
    Reported Nov 10
    		$-0.27$-0.30+10.63%Beat+3.6%
    Jun 25
    Reported Aug 5
    		$-0.26$-0.29+10.90%Beat+16.1%
    Mar 25
    Reported May 12
    		$-0.26$-0.27+3.77%Beat+13.3%
    Dec 24
    Reported Mar 12
    		$-0.24$-0.30+20.05%Beat+17.2%
    Sep 24
    Reported Nov 12
    		$-0.28$-0.32+12.50%Beat+33.3%
    Jun 24
    Reported Aug 5
    		$-0.31$-0.34+8.82%Beat-24.0%
    Mar 24
    Reported May 13
    		$-0.30$-0.34+11.76%Beat+3.2%
    Dec 23
    Reported Mar 14
    		$-0.29$-0.29+0.00%Beat+0.0%
    Sep 23
    Reported Nov 14
    		$-0.42$-0.31-35.48%Miss+4.5%
    Jun 23
    Reported Aug 8
    		$-0.25$-0.34+26.47%Beat+54.5%
    Mar 23
    Reported May 15
    		$-0.31$-0.27-14.81%Miss+43.6%
    Dec 22
    Reported Mar 27
    		$-0.29$-0.43+32.56%Beat+48.2%
    Sep 22
    Reported Nov 9
    		$-0.44$-0.52+15.38%Beat+6.4%
    Jun 22
    Reported Aug 8
    		$-0.55$-0.59+6.78%Beat-27.9%
    Mar 22
    Reported May 16
    		$-0.55$-0.64+14.06%Beat+37.5%
    Dec 21
    Reported Mar 3
    		$-0.56$-0.63+11.11%Beat+98.2%
    Sep 21
    Reported Nov 15
    		$-0.47$-0.60+21.67%Beat-
    Jun 21
    Reported Aug 16
    		$-0.43$-0.71+39.44%Beat-
    Mar 21
    Reported May 14
    		$-0.88$-0.77-14.29%Miss-
    Dec 20
    Reported Mar 30
    		$-30.94$-0.91-3300.00%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$52.91
    SMA 20$52.80
    SMA 50$49.45
    SMA 200$27.99
    EMA 10$52.89
    EMA 20$52.45
    EMA 50$49.19
    EMA 200$32.59

    MACD

    Line: 0.90Signal: 1.20Hist: -0.30

    ADX

    ADX: 49.6+DI: 29.5-DI: 9.0

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down20.0
    PSAR$53.00

    Bollinger Bands

    Upper Band$53.07
    Lower Band$52.52
    %B Position103%(Upper)
    Band Width0.78

    RSI (14-Day)

    Overbought
    73.9

    Momentum Oscillators

    Stoch %K91.0
    Stoch %D89.8
    Williams %R-8.1
    ROC (10d)0.2%
    Momentum0.09
    CCI (20d)86.3
    MFI (14d)71.2

    Volatility Measures

    ATR (14d)$0.40(0.7%)
    StdDev (20d)0.14
    Hist Vol1.6%(Low)

    Volume Flow

    VWAP$52.95
    OBV193.1M
    AD Line53.1M
    CMF (20d)-0.083

    Volume Metrics

    Avg Vol (20d)4.8M
    Vol RatioN/A
    VWMA (20d)$52.74

    Pivot Points

    R3$53.01
    R2$53.00
    R1$52.97
    Pivot Point$52.96
    S1$52.93
    S2$52.92
    S3$52.89

    Advanced Oscillators

    TSI48.19
    Ultimate Osc48.0
    KST68.91

    Financial Data

    QuarterDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Total Revenue$0$0$0$0$0$0$0$0$1.32M$0$0$0
    Cost of Revenue$-108,000$0$0$0N/A$0$0$0$220,000$0$0$0
    Gross Profit$108,000$0$0$0N/A$0$0$0$1.10M$0$0$0
    Operating Expenses$27.60M$27.72M$27.38M$27.43M$25.95M$24.94M$25.54M$25.45M$24.06M$33.18M$21.16M$24.16M
    R&D$18.90M$19.92M$20.35M$18.72M$18.00M$15.17M$18.35M$18.59M$17.46M$14.83M$14.15M$17.06M
    SG&A$8.70M$7.80M$7.03M$8.71M$7.95M$9.77M$7.18M$6.86M$6.60M$18.35M$7.01M$7.10M
    Operating Income$-27,598,000$-27,716,000$-27,383,000$-27,427,000$-25,949,000$-24,939,000$-25,537,000$-25,446,000$-24,058,000$-33,184,000$-21,159,000$-24,157,000
    Interest Income$4.46M$3.14M$3.35M$3.64M$4.14M$3.09M$2.88M$3.18M$3.33M$3.48M$3.40M$2.69M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-23,188,000$-24,589,000$-24,029,000$-23,820,000$-21,759,000$-21,883,000$-22,675,000$-22,276,000$-20,970,000$-29,709,000$-17,824,000$-21,468,000
    Income Tax Expense$383,000$46,000$64,000$88,000$40,000$62,000$61,000$97,000$49,000$58,000$72,000$60,000
    Net Income$-23,571,000$-24,635,000$-24,093,000$-23,908,000$-21,799,000$-21,945,000$-22,736,000$-22,373,000$-21,019,000$-29,767,000$-17,896,000$-21,528,000
    EBITDA$-27,532,000$-27,484,000$-27,406,000$-27,294,000$-23,798,000$-26,655,000$-25,311,000$-25,222,000$-24,083,000$-32,967,000$-21,002,000$-23,939,000
    EBIT$-27,645,000$-27,730,000$-27,379,000$-27,463,000$-25,902,000$-24,971,000$-25,551,000$-25,458,000$-24,303,000$-33,189,000$-21,219,000$-24,161,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TERN

    News

    Merck nears deal to buy Terns Pharmaceuticals

    The article reports that pharmaceutical giant Merck is close to finalizing an agreement to acquire Terns Pharmaceuticals. This acquisition would signify Merck's strategic move to expand its drug portfolio, potentially in areas where Terns Pharmaceuticals has a strong presence. The details regarding the terms of a potential deal were not disclosed in this snippet.

    MSN•6/26/26•
    Somewhat-Bullish

    Terns Pharmaceuticals Inc (TERN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

    This article provides a technical analysis of Terns Pharmaceuticals Inc (TERN), detailing its support, resistance levels, and various technical indicators. It shows that based on moving averages and several indicators, the current signal for TERN is a "Buy", with 6 buy signals from moving averages and a mix of buy, neutral, and sell signals from other technical indicators. The article also includes FAQs explaining technical ratings and moving averages.

    TradingKey•6/19/26•
    Bullish

    Terns Pharmaceuticals Inc (TERN) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for Terns Pharmaceuticals Inc (TERN), highlighting analyst expectations for its price target, EPS, and revenue growth. While the price target is set at $15.00, with a range from $7.44 to $28.00, specific future EPS and revenue data are not yet disclosed by the company. The article notes that TERN's previous quarter EPS was -$0.27, slightly below the market expectation of -$0.24, with the next quarter's EPS also expected to be -$0.27.

    TradingKey•6/18/26•
    Neutral

    Terns Pharmaceuticals Inc (TERN) Institutional Confidence

    This article provides an "Institutional Confidence" snapshot for Terns Pharmaceuticals Inc (TERN), listing key institutional shareholders and their recent changes in shareholdings. Major holders include Morgan Stanley & Co. LLC, BlackRock Institutional Trust Company, N.A., and Adage Capital Management, L.P., with some exhibiting significant percentage increases in their TERN shares. The data highlights institutional investment activity in the company.

    TradingKey•6/18/26•
    Neutral

    Morgan Stanley no longer >5% holder of Terns Pharmaceuticals (TERN)

    Morgan Stanley has filed a Schedule 13G/A, formally reporting that it no longer beneficially owns more than 5% of Terns Pharmaceuticals (TERN) common stock. The filing indicates a beneficial ownership of 0.0% as of an effective date of May 31, 2026, and was signed on June 5, 2026. This amendment aligns with regulatory obligations for large shareholders falling below the 5% ownership threshold.

    Stock Titan•6/5/26•
    Neutral

    Frequently Asked Questions About TERN

    Does TERN pay dividends?
    TERN (TERN) does not currently pay a regular dividend.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In